Lista de obras - Y Wang - Dominio Público Uruguay

Activation of MYC, a bona fide client of HSP90, contributes to intrinsic ibrutinib resistance in mantle cell lymphoma

artículo científico publicado en 2018

Activation of peroxisome proliferator-activated receptor gamma contributes to the survival of T lymphoma cells by affecting cellular metabolism.

artículo científico publicado en 2007

Activities of SYK and PLCgamma2 predict apoptotic response of CLL cells to SRC tyrosine kinase inhibitor dasatinib.

artículo científico publicado en 2010

Amplicon Indel Hunter Is a Novel Bioinformatics Tool to Detect Large Somatic Insertion/Deletion Mutations in Amplicon-Based Next-Generation Sequencing Data.

artículo científico publicado en 2015

Amplification refractory mutation system, a highly sensitive and simple polymerase chain reaction assay, for the detection of JAK2 V617F mutation in chronic myeloproliferative disorders

artículo científico publicado en 2007

An evaluation of the Factor V Leiden mutation in a cohort of African-American pregnant women ⬇️

artículo científico publicado el 1 de abril de 1998

Atypical serum immunofixation patterns frequently emerge in immunomodulatory therapy and are associated with a high degree of response in multiple myeloma

artículo científico publicado en 2008

B-Cell Lymphoma Patient-Derived Xenograft Models Enable Drug Discovery and Are a Platform for Personalized Therapy

artículo científico publicado en 2017

BTK inhibition targets in vivo CLL proliferation through its effects on B-cell receptor signaling activity

artículo científico publicado en 2013

Cerdulatinib pharmacodynamics and relationships to tumor response following oral dosing in patients with relapsed/refractory B-cell malignancies

artículo científico publicado en 2018

Cerdulatinib, a novel dual SYK/JAK kinase inhibitor, has broad anti-tumor activity in both ABC and GCB types of diffuse large B cell lymphoma.

artículo científico publicado en 2015

Certification in molecular pathology in the United States: an update from the Association for Molecular Pathology Training and Education Committee.

artículo científico publicado en 2012

Characterization of ibrutinib-sensitive and -resistant mantle lymphoma cells.

artículo científico publicado en 2014

Clonal evolution underlying leukemia progression and Richter transformation in patients with ibrutinib-relapsed CLL

scientific article published on 02 May 2017

Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials.

artículo científico publicado en 2008

Detection of BCL2-IGH using single-round PCR assays.

artículo científico publicado en 2005

Evaluation of JAK2 in B and T cell neoplasms: identification of JAK2(V617F) mutation of undetermined significance (JMUS) in the bone marrow of three individuals

artículo científico publicado en 2007

Functional characterization of BTK(C481S) mutation that confers ibrutinib resistance: exploration of alternative kinase inhibitors.

artículo científico publicado en 2014

Heightened BTK-dependent cell proliferation in unmutated chronic lymphocytic leukemia confers increased sensitivity to ibrutinib

artículo científico publicado en 2015

Ibrutinib resistance in chronic lymphocytic leukemia

artículo científico publicado en 2014

Identification of a structurally novel BTK mutation that drives ibrutinib resistance in CLL.

artículo científico publicado en 2016

JAK2 Mutations are present in all cases of polycythemia vera

artículo científico publicado en 2007

JAK2(V617F) allele burden in polycythemia vera correlates with grade of myelofibrosis, but is not substantially affected by therapy

artículo científico publicado en 2010

JAK2V617F allele burden is reduced by busulfan therapy: a new observation using an old drug.

artículo científico publicado en 2013

Laboratory detection of JAK2V617F in human myeloproliferative neoplasms

artículo científico publicado en 2013

Laboratory practice guidelines for detecting and reporting JAK2 and MPL mutations in myeloproliferative neoplasms: a report of the Association for Molecular Pathology.

artículo científico publicado en 2013

Metabolic Detection of Bruton's Tyrosine Kinase Inhibition in Mantle Cell Lymphoma Cells

artículo científico publicado en 2019

Molecular monitoring of chronic myelogenous leukemia: identification of the most suitable internal control gene for real-time quantification of BCR-ABL transcripts.

artículo científico publicado en 2006

Molecular monitoring of chronic myeloid leukemia: international standardization of BCR-ABL1 quantitation.

artículo científico

NK/T cell non-Hodgkin lymphoma in a HIV-positive patient.

artículo científico publicado en 2010

Novel bcl-2 breakpoints in patients with follicular lymphoma

artículo científico publicado en 1998

Predicting Prognosis in Chronic Lymphocytic Leukemia in the Contemporary Era.

artículo científico

Prognosis in Chronic Lymphocytic Leukemia-Reply.

artículo científico publicado en 2015

Regulation of self-tolerance by CD80/CD86 interactions

artículo científico publicado en 1997

Requirements for U2 snRNP addition to yeast pre-mRNA.

artículo científico publicado en 1992

SYK inhibition and response prediction in diffuse large B-cell lymphoma ⬇️

artículo científico publicado el 24 de octubre de 2011

Splenic extramedullary hematopoietic proliferation in Philadelphia chromosome-negative myeloproliferative neoplasms: heterogeneous morphology and cytological composition.

artículo científico publicado en 2012

Strongyloides stercoralis infection presenting as an unusual cause of massive upper gastrointestinal bleeding in an immunosuppressed patient: a case report.

artículo científico publicado en 2013

The proapoptotic factors Bax and Bak regulate T Cell proliferation through control of endoplasmic reticulum Ca(2+) homeostasis

artículo científico publicado en 2007

Thiazolidinedione activation of peroxisome proliferator-activated receptor gamma can enhance mitochondrial potential and promote cell survival.

artículo científico publicado en 2002

To Live or to Die: Prosurvival Activity of PPARgamma in Cancers

artículo científico publicado en 2008

Translating Trial-Based Molecular Monitoring Into Clinical Practice: Importance of International Standards and Practical Considerations for Community Practitioners ⬇️

artículo científico publicado el 10 de mayo de 2011

Tyrosine kinase inhibition in diffuse large B-cell lymphoma: molecular basis for antitumor activity and drug resistance of dasatinib.

artículo científico publicado en 2008

XPO1 Inhibitor Selinexor Overcomes Intrinsic Ibrutinib Resistance in Mantle Cell Lymphoma via Nuclear Retention of IκB

scientific article published on 01 December 2018

Lista de obras de Y Wang

Activation of MYC, a bona fide client of HSP90, contributes to intrinsic ibrutinib resistance in mantle cell lymphoma

Activation of peroxisome proliferator-activated receptor gamma contributes to the survival of T lymphoma cells by affecting cellular metabolism.

Activities of SYK and PLCgamma2 predict apoptotic response of CLL cells to SRC tyrosine kinase inhibitor dasatinib.

Amplicon Indel Hunter Is a Novel Bioinformatics Tool to Detect Large Somatic Insertion/Deletion Mutations in Amplicon-Based Next-Generation Sequencing Data.

Amplification refractory mutation system, a highly sensitive and simple polymerase chain reaction assay, for the detection of JAK2 V617F mutation in chronic myeloproliferative disorders

An evaluation of the Factor V Leiden mutation in a cohort of African-American pregnant women ⬇️

Atypical serum immunofixation patterns frequently emerge in immunomodulatory therapy and are associated with a high degree of response in multiple myeloma

B-Cell Lymphoma Patient-Derived Xenograft Models Enable Drug Discovery and Are a Platform for Personalized Therapy

BTK inhibition targets in vivo CLL proliferation through its effects on B-cell receptor signaling activity

Cerdulatinib pharmacodynamics and relationships to tumor response following oral dosing in patients with relapsed/refractory B-cell malignancies

Cerdulatinib, a novel dual SYK/JAK kinase inhibitor, has broad anti-tumor activity in both ABC and GCB types of diffuse large B cell lymphoma.

Certification in molecular pathology in the United States: an update from the Association for Molecular Pathology Training and Education Committee.

Characterization of ibrutinib-sensitive and -resistant mantle lymphoma cells.

Clonal evolution underlying leukemia progression and Richter transformation in patients with ibrutinib-relapsed CLL

Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials.

Detection of BCL2-IGH using single-round PCR assays.

Evaluation of JAK2 in B and T cell neoplasms: identification of JAK2(V617F) mutation of undetermined significance (JMUS) in the bone marrow of three individuals

Functional characterization of BTK(C481S) mutation that confers ibrutinib resistance: exploration of alternative kinase inhibitors.

Heightened BTK-dependent cell proliferation in unmutated chronic lymphocytic leukemia confers increased sensitivity to ibrutinib

Ibrutinib resistance in chronic lymphocytic leukemia

Identification of a structurally novel BTK mutation that drives ibrutinib resistance in CLL.

JAK2 Mutations are present in all cases of polycythemia vera

JAK2(V617F) allele burden in polycythemia vera correlates with grade of myelofibrosis, but is not substantially affected by therapy

JAK2V617F allele burden is reduced by busulfan therapy: a new observation using an old drug.

Laboratory detection of JAK2V617F in human myeloproliferative neoplasms

Laboratory practice guidelines for detecting and reporting JAK2 and MPL mutations in myeloproliferative neoplasms: a report of the Association for Molecular Pathology.

Metabolic Detection of Bruton's Tyrosine Kinase Inhibition in Mantle Cell Lymphoma Cells

Molecular monitoring of chronic myelogenous leukemia: identification of the most suitable internal control gene for real-time quantification of BCR-ABL transcripts.

Molecular monitoring of chronic myeloid leukemia: international standardization of BCR-ABL1 quantitation.

NK/T cell non-Hodgkin lymphoma in a HIV-positive patient.

Novel bcl-2 breakpoints in patients with follicular lymphoma

Predicting Prognosis in Chronic Lymphocytic Leukemia in the Contemporary Era.

Prognosis in Chronic Lymphocytic Leukemia-Reply.

Regulation of self-tolerance by CD80/CD86 interactions

Requirements for U2 snRNP addition to yeast pre-mRNA.

SYK inhibition and response prediction in diffuse large B-cell lymphoma ⬇️

Splenic extramedullary hematopoietic proliferation in Philadelphia chromosome-negative myeloproliferative neoplasms: heterogeneous morphology and cytological composition.

Strongyloides stercoralis infection presenting as an unusual cause of massive upper gastrointestinal bleeding in an immunosuppressed patient: a case report.

The proapoptotic factors Bax and Bak regulate T Cell proliferation through control of endoplasmic reticulum Ca(2+) homeostasis

Thiazolidinedione activation of peroxisome proliferator-activated receptor gamma can enhance mitochondrial potential and promote cell survival.

To Live or to Die: Prosurvival Activity of PPARgamma in Cancers

Translating Trial-Based Molecular Monitoring Into Clinical Practice: Importance of International Standards and Practical Considerations for Community Practitioners ⬇️

Tyrosine kinase inhibition in diffuse large B-cell lymphoma: molecular basis for antitumor activity and drug resistance of dasatinib.

XPO1 Inhibitor Selinexor Overcomes Intrinsic Ibrutinib Resistance in Mantle Cell Lymphoma via Nuclear Retention of IκB